At 3.1% CAGR, the South & Central America Nanoparticle Measurement Instrument Market is Projected to be Worth US$ 378.88 Million by 2031, Says Business Market Insights

According to Business Market Insights' research, the South & Central America nanoparticle measurement instrument market was valued at US$ 296.78 million in 2023 and is expected to reach US$ 378.88 million by 2031, registering a CAGR of 3.1% from 2023 to 2031. Emergence of nanoparticle-based drug delivery systems and integration of artificial intelligence and machine learning are among the critical factors attributed to the South & Central America nanoparticle measurement instrument market expansion.

Several research activities are being carried out on drug delivery using nanotechnology. Nanotechnology contributes significantly to the effectiveness and potency of chronic disease treatments through site-specific and target-oriented delivery of precise medicines in humans. Various nanomedicine agents have been studied for their application in chemotherapy and immunotherapy. Recent efforts to advance nano-based drug delivery systems and nanomedicine have been focused on improving drug delivery by using the efficacy and selectiveness of nanomaterials. The use of large-sized materials in drug delivery poses substantial challenges, which include poor bioavailability, in vivo instability, poor solubility, issues with target-specific delivery, and sub-optimal absorption within the body. Nanotechnology plays a significant role in advanced medicine/drug formulations, as their size, shape, and surface chemistry can be adjusted to benefit from the unique properties of nanoscale materials and structures; this allows tailoring their functionalities for different biomedical applications. For instance, lipid nanoparticles (LNPs) are being studied by AstraZeneca as a novel and promising delivery system for nucleotide-based medicines that produce therapeutic proteins inside target cells. Creative Biolabs offers sophisticated formulation development systems for APIs. Its particle and nanoparticle engineering technologies enable an array of nanotechnology-based drug delivery platforms. The business also sells polymeric nanoparticles, liposomes, and nanocrystals. Thus, continuous developments in nanotechnology-based drug delivery systems are expected to generate significant opportunities for the nanoparticle measurement instrument market in the coming years.

On the contrary, high cost of instruments hampers the growth of South & Central America nanoparticle measurement instrument market.

Based on type, the South & Central America nanoparticle measurement instrument market is segmented into X-Ray diffractometer, scanning electron microscope, atomic force microscope, photon correlation spectroscopy, nanoparticle surface area monitor, transmission electron microscope, condensation particle counter, differential mobility analyzer, scanning mobility particle sizer, nanoparticle tracking analyzer, aerosol particle mass analyzer, and others. The transmission electron microscope segment held 21.1% share of the South & Central America nanoparticle measurement instrument market in 2023, amassing US$ 62.58 million. It is projected to garner US$ 82.70 million by 2031 to expand at 3.5% CAGR during 2023–2031.

Based on end user, the South & Central America nanoparticle measurement instrument market is segmented into biotechnology industry, pharmaceutical industry, contract research organizations (CROs), and others. The pharmaceutical industry segment held 38.4% share of the South & Central America nanoparticle measurement instrument market in 2023, amassing US$ 113.99 million. It is projected to garner US$ 149.60 million by 2031 to expand at 3.5% CAGR during 2023–2031.

Based on country, the South & Central America nanoparticle measurement instrument market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil held 56.6% share of South & Central America nanoparticle measurement instrument market in 2023, amassing US$ 167.88 million. It is projected to garner US$ 216.27 million by 2031 to expand at 3.2% CAGR during 2023–2031.

Key players operating in the nanoparticle measurement instrument market are Bruker; Spectradyne LLC.; Malvern Panalytical Ltd; IZON Science LTD; Particle Metrix GmbH; Microtrac Retsch GmbH; Horiba Ltd; Angstrom Advanced Inc.; Shimadzu Corp; and Yokogawa Electric Corp, among others.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com